1. Cancer Stat Facts: Ovarian Cancer: National Cancer Institiute. Surveillance, Epidemiology, and End Results Program. Available at: https://seer.cancer.gov/statfacts/html/ovary.html.
2. Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. 2019;30(5):672–705. https://doi.org/10.1093/annonc/mdz062. (Epub 2019/05/03).
3. Armstrong DK AR, Backes FJ, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuk A, Chen LM, Chitiyo V, Cristea M, Derosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Gisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Leiserowitz G, Liu J, Martin L, Matei D, McHale M, McLean K, Miller DS, Percac-Lima S, Remmenga SW, Robertson S, Rodabaugh K, Schorge J, Stewart D, Thaker PH, Vargas R, Wahner Hendrickson A, Werner TL, Zsiros E. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 5.2022.
4. Jones RB, Myers CE, Guarino AM, Dedrick RL, Hubbard SM, DeVita VT. High-volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer. Pharmacologic basis and early results. Cancer Chemother Pharmacol. 1978;1(3):161–6. https://doi.org/10.1007/bf00253116. (Epub 1978/01/01).
5. Los G, Mutsaers PH, van der Vijgh WJ, Baldew GS, de Graaf PW, McVie JG. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res. 1989;49(12):3380–4 (Epub 1989/06/15).